NINIVAGGI DANIEL A 4

What Happened

• Daniel A. Ninivaggi, a director of Indivior Pharmaceuticals, Inc. (INDV), was granted 6,518 restricted stock units (RSUs) on 2026-05-13. The award shows an acquisition price of $0.00 (no cash paid). This is a grant of equity compensation, not an open-market purchase or sale.

Key Details

• Transaction date: 2026-05-13 (reported on Form 4 filed 2026-05-14)
• Transaction type/code: Award/Grant (A)
• Shares/units granted: 6,518 RSUs; price reported $0.00
• Vesting: RSUs vest on the day immediately preceding the date of the annual meeting following the grant, subject to continued service (per footnote)
• Shares owned after transaction: Not specified in the provided excerpt of the filing
• Timeliness: Filing appears timely (period of report 2026-05-13; Form 4 filed 2026-05-14)

Context

• RSUs represent a contingent right to receive common stock at vesting (one share per RSU). They are commonly used as director compensation and do not involve an immediate cash outlay or open-market trading. Such grants are routine and reflect compensation practices more than an insider buying or selling shares.